Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Candidate drug receives US$120M in funding for late-stage testing

Mogrify relocates to the Bio-Innovation Centre and Canadian clinics continue to provide stem cell therapies without federal approval.

Go to the profile of RegMedNet
May 23, 2019

Please sign in or register for FREE

No comments yet.